About: EMA
EFSA boss: Next time we should also assess consequences without glyphosate
The next re-authorisation process for the controversial glyphosate weedkiller should also include an assessment of a potential ban of the substance in terms of food availability, biodiversity and farmers’ income, Bernhard Url told EURACTIV.com in an interview.
Brexit turns EU into landlord in the City of London
The European Medicines Agency is looking to sublet its former headquarters in the financial district of London, after a British court ruled on Wednesday (20 February) that it cannot break its lease despite the UK’s withdrawal from the EU.
Does fast-track drugs approval in EU run too fast?
More than two years after its launch, the EU's fast-track approval process for marketing new drugs, called PRIME, is broadly welcomed by patients and industry, walking the fine line between patients' safety and expediency, and between the need to foster innovation and remaining abuse-proof.
NHS faces ‘serious challenges’ from Brexit, warns new report
Brexit poses “serious challenges” to the NHS in the form of longer waiting times, staff shortages and delays in the approval of new medicines, according to a report published on Wednesday (14 March).
Italian pharma chief: Dutch EMA bid ‘may have misled’ the Commission
The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.
Italy cries foul over temporary accommodation of EU Medicines Agency
Dutch officials and the head of the European Medicines Agency (EMA) sought yesterday (29 January) to allay any jitters among the agency's 900 London-based staff who are being asked to move to Amsterdam because of Britain's departure from the EU.
Stakeholders call for more transparent meetings between pharma and EMA
Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the continent’s healthcare industry, should be more transparent.
Access to clinical trials and innovative treatments at risk after Brexit
LONDON: Patients in Britain risk delays to access life-saving medicines if the UK deviates from EU regulatory standards post-Brexit, a leading medical representative has warned.
Paris celebrates the arrival of the European Banking Authority
At the end of a suspenseful day, delegates from 27 EU governments meeting in the General Affairs Council chose to relocate the European Medicines Agency to Amsterdam and the European Banking Authority to Paris. EURACTIV France reports.
Amsterdam, Paris take EU agencies in lucky dip thriller
Amsterdam and Paris won the right to host the two EU agencies that must leave London on Brexit after a dramatic ministerial meeting in Brussels on Monday (20 November) that left both result decided by drawing lots after votes were tied.
Fate of banking, medicines agencies to be decided by secret ballot
EU ministers will vote by secret ballot on the relocation of two EU agencies currently based in London at the General Affairs Council on 20 November. The ballot papers will then be destroyed and no record kept.
EMA relocation should consider the wellbeing of all Europeans
The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in order, writes Sandro Gozi.
Croatia minister on EMA: ‘Moral’ obligation to favour a country without EU agency
In assessing the relocation of the EU drugs agency EMA, old member states have a "moral and political obligation" to give an advantage to those candidate countries that do not currently host another EU agency, Croatia’s health minister told EURACTIV.com.
Greek minister: EMA bid shows drugs are a social good
Athens’ decision to claim the European Medicine Agency's relocation from London sends a message that medicine is “not just a commodity but a social good”, Greece’s Alternate Minister of Foreign Affairs, Georgios Katrougalos, told EURACTIV.com.
EU drug agency announces ‘business continuity’ plan amid relocation uncertainty
The European Medicines Agency (EMA) presented on Tuesday (1 August) a business continuity plan aimed at tackling the potential challenges poised by its relocation from London to another member state after the Brexit decision.
EU states compete to host London-based agencies after Brexit
All but six European Union states are bidding to host one or both the London-based EU agencies that will be relocated after Brexit, setting up a competition that could easily escalate into a squabble.
Deadline for race to host EU agencies after Brexit
European Union countries faced a deadline Monday to submit their bids to host the post-Brexit locations of key banking and medical agencies currently based in London.
Athens and Milan throw names into EU medicines agency hat
Hosting the European Medicines Agency brings considerable economic benefits to the host city as the service employs more than 1,000 people, paid by the EU. Athens and Milan are keen to secure a slice of this lucrative pie.
Spain plays down tensions with Catalonia in its bid for EMA
Spanish Minister for Health Dolors Montserrat said today (24 May) that Barcelona is “first in the class” in meeting all the criteria to host the European Medicines Agency (EMA). She also insisted that the central government supports Catalonia's bid to host it after Brexit.
Portuguese minister: Southern cities better placed to host medicines agency
Portugal is the latest member state to try and poach the UK-based European Medicines Agency after Brexit. In an interview with EURACTIV.com, Portugal’s junior minister for European affairs insisted having two EU agencies based in Lisbon already would not hurt its chances.
Strasbourg could trade Parliament seat for medicines agency
EU officials claim there is growing support for a proposal to close the European Parliament’s expensive second seat in Strasbourg and to sweeten the deal by giving the French city the European Medicine Agency in return.
Brexit will cost Greece up to 0.8% of GDP, minister says
The British exit from the European Union will have consequences for the Greek economy, especially on tourism, Deputy Minister of Foreign Affairs George Katrougalos said on Monday (8 May).
Allowing patients to choose could save billions
The Commission’s recent musings on the social dimension of Europe touches on common drug pricing among member states. But it misses out on solutions for faster access to medicine, Fred Roeder.